VF
TGTX icon

Virtu Financial’s TG Therapeutics TGTX Stock Holding History

Virtu Financial’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$963K Buy
+17,524
New +$717K 0.03% 329
2023
Q2 		– Sell
-21,224
Closed -$319K – 2036
2023
Q1 		$319K Buy
+21,224
New +$322K 0.03% 519
2022
Q3 		– Sell
-12,191
Closed -$52K – 2236
2022
Q2 		$52K Sell
12,191
-8,374
-41% -$52.3K ﹤0.01% 1118
2022
Q1 		$196K Buy
+20,565
New +$238K 0.01% 789
2021
Q3 		– Sell
-6,493
Closed -$252K – 1956
2021
Q2 		$252K Buy
+6,493
New +$255K 0.02% 830
2021
Q1 		– Sell
-17,330
Closed -$902K – 2017
2020
Q4 		$902K Buy
+17,330
New +$586K 0.1% 254
2020
Q3 		– Sell
-10,477
Closed -$204K – 1505
2020
Q2 		$204K Buy
+10,477
New +$169K 0.02% 721
2019
Q4 		$361K Buy
32,551
+20,278
+165% +$154K 0.04% 579
2019
Q3 		$69K Buy
+12,273
New +$85.6K 0.01% 1145
2019
Q1 		– Sell
-51,570
Closed -$211K – 1834
2018
Q4 		$211K Buy
51,570
+41,245
+399% +$205K 0.01% 932
2018
Q3 		$58K Buy
+10,325
New +$118K ﹤0.01% 1280
2018
Q2 		– Sell
-36,592
Closed -$520K – 2493
2018
Q1 		$520K Sell
36,592
-9,463
-21% -$121K 0.03% 682
2017
Q4 		$378K Buy
46,055
+25,943
+129% +$227K 0.02% 1068
2017
Q3 		$238K Buy
+20,112
New +$229K 0.01% 1635

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

Virtu Financial's TGTX Position: Q2 2026 in Review

Virtu Financial opened a new position in TG Therapeutics (TGTX) in Q2 2026: 17,524 shares worth $963K. The stake represents 0.03% of the portfolio and ranks #329 among its holdings. This is a return to the name: Virtu Financial previously reported a position in TGTX as recently as Q1 2023.

Virtu Financial first reported a position in TGTX in Q3 2017 and has held it in 14 quarters since. 431 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Virtu Financial held 17,524 shares of TG Therapeutics worth $963K as of Q2 2026.
  • TG Therapeutics was a new Virtu Financial position in Q2 2026.
  • TG Therapeutics made up 0.03% of Virtu Financial's portfolio in Q2 2026, its #329 holding.
  • Virtu Financial first reported a position in TG Therapeutics in Q3 2017 and has held it in 14 quarters since.
  • 431 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.